{"schema_version":"secwatch.filing_event.v1","accession":"0001576885-24-000018","form_type":"8-K","ticker":"ABOS","cik":"0001576885","company_name":"Acumen Pharmaceuticals, Inc.","filed_at":"2024-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.676751+00:00","generated_at":"2026-06-06T23:53:14.587908+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Acumen Pharmaceuticals posts updated corporate presentation; no material new information disclosed","bullets":["Filed under Item 7.01; presentation posted to company website on January 12, 2024.","Presentation covers corporate overview and strategy but no specific financial or clinical updates in the excerpt provided.","No new earnings, guidance, trial results, or other material events referenced in the filing or exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001576885-24-000018","json":"https://secwatch.observer/filing/0001576885-24-000018.json","markdown":"https://secwatch.observer/filing/0001576885-24-000018.md","text":"https://secwatch.observer/filing/0001576885-24-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1576885/000157688524000018/0001576885-24-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1576885/000157688524000018/abos-20240112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:53:14.587908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}